The Federal requirements for transmission of health information stemming from substance use disorder treatment have received an update. The changes include the adoption of a consent process for multiple entities through a single release of information. This applies to HIPAA covered entities and business associates, and can be used for purposes of treatment, payment, and operation of health care services.